Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 4 of 18
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
NCT03312686
Indiana University Gastrointestinal Motility Diagnosis Registry
NCT04506593
Pediatric Cardiomyopathy Mutation Analysis
NCT02432092
GI Neuromuscular Pathology Prospective Registry
NCT02165059
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
NCT02432079
Alzheimer's Disease Genetics Study
NCT00064870
Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer
NCT07228637
Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task
NCT07447882
A Comparison of Satiety Effects Two Commercially Available Snack Bars
NCT07227701
Using EMR Data and AI to Develop a Passive Digital Marker to Predict Postoperative Delirium
NCT06216483
Electronic Diabetes Tune-Up Group (eDTU) for African Americans
NCT06321029
Maternal Brain Imaging in Opioid Use Disorder
NCT06008990
Evidence-based Pediatric Obstructive Sleep Apnea Detection
NCT05908110
Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure
NCT05601817
Intervention to Change Affect Recognition and Empathy
NCT05636020
Telemedicine for Children With Sickle Cell Disease
NCT05087303
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma
NCT05119036
Pregnancy at a Time That Is Happy and Healthy for You
NCT05216003
Integrative Medicine in Pain Management in Sickle Cell Disease
NCT05045820
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
NCT04811521
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
NCT04383951
Reducing Risk of Dementia Through Deprescribing
NCT04270474
ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve
NCT06491758
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
NCT04206436
Incontinence and Quality of Life in Children With Spina Bifida
NCT03410667
Vagus Nerve Response in Gastroparesis Patients
NCT04207996
Effect of Stimulation on the Vagus Nerve
NCT04206540
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature
NCT03906708
Physical Therapy for Men Undergoing Prostatectomy
NCT02558946
Upper Airway Microbial Development During the First Year of Life
NCT01978288
Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve
NCT02159586
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
NCT03728842
The Role of Environmental Temperatures in Respiratory Control
NCT07470086
The Role of Breathing Perception in Respiratory Control
NCT07470099
Reciprocal Innovation to Optimize Low-Tech Augmentative and Alternative Communication (AAC) for Individuals
NCT07581483
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2
NCT06783504
Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease
NCT06253884
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
NCT07499583
Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects
NCT06000540
Lifestyle Interventions to Improve Glycemic Parameters and Reduce Gestational Diabetes in High-risk Pregnant Individuals
NCT06445270
Testing Scalable Caregiver Interventions for Autism
NCT07259044
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease
NCT06045988
Overground Virtual Reality (VR) Gait Rehabilitation for Traumatic Brain Injury (TBI)
NCT07038889
Using Virtual Reality Travel to Reduce Loneliness in Older Adults
NCT07644416
MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients
NCT07540585
Supporting Families in the ICU
NCT07228299
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
NCT07389525
Finding Immune Nascent Type 1 Diabetes
NCT07663136
Comparing Approaches to Helping People With Chronic Traumatic Brain Injury Manage Their Health Care
NCT07483528
Impact of Standardization on Outcomes Following Cervical Ripening
NCT07576881
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.